This study aimed to assess the effectiveness of dental sound insulation in alleviating stress and fear during dental scaling in pediatric patients. It also examined the influence of a noise-canceling application on dentist-patient communication and convenience of dental procedures. This study included 60 children and adolescents aged 7 - 16 years between April 2022 and March 2023. All participants underwent dental plaque control using an ultrasonic scaler on the maxilla first, followed by plaque control on the mandible. Dental sound insulation with active noise canceling was randomly applied to either the maxilla or mandible. Findings revealed that the stress index was significantly reduced when the application was used, with a score of 5.85 compared to 8.43 without it (p < 0.0001). Similarly, the dental fear score was significantly reduced to 1.17 with the application, as opposed to 2.97 without it (p < 0.0001). The dental sound insulation did not affect the communication between dentists and patients or the convenience of treatment. This study demonstrated that active noise canceling during pediatric dental care significantly reduced stress and fear, suggesting that it could be a valuable behavior guidance tool, particularly for children who find dental visits challenging.

This study aimed to assess the effectiveness of dental sound insulation in alleviating stress and fear during dental scaling in pediatric patients. It also examined the influence of a noise-canceling application on dentist-patient communication and convenience of dental procedures. This study included 60 children and adolescents aged 7 - 16 years between April 2022 and March 2023. All participants underwent dental plaque control using an ultrasonic scaler on the maxilla first, followed by plaque control on the mandible. Dental sound insulation with active noise canceling was randomly applied to either the maxilla or mandible. Findings revealed that the stress index was significantly reduced when the application was used, with a score of 5.85 compared to 8.43 without it (p < 0.0001). Similarly, the dental fear score was significantly reduced to 1.17 with the application, as opposed to 2.97 without it (p < 0.0001). The dental sound insulation did not affect the communication between dentists and patients or the convenience of treatment. This study demonstrated that active noise canceling during pediatric dental care significantly reduced stress and fear, suggesting that it could be a valuable behavior guidance tool, particularly for children who find dental visits challenging.

This study aimed to assess the effectiveness of dental sound insulation in alleviating stress and fear during dental scaling in pediatric patients. It also examined the influence of a noise-canceling application on dentist-patient communication and convenience of dental procedures. This study included 60 children and adolescents aged 7 - 16 years between April 2022 and March 2023. All participants underwent dental plaque control using an ultrasonic scaler on the maxilla first, followed by plaque control on the mandible. Dental sound insulation with active noise canceling was randomly applied to either the maxilla or mandible. Findings revealed that the stress index was significantly reduced when the application was used, with a score of 5.85 compared to 8.43 without it (p < 0.0001). Similarly, the dental fear score was significantly reduced to 1.17 with the application, as opposed to 2.97 without it (p < 0.0001). The dental sound insulation did not affect the communication between dentists and patients or the convenience of treatment. This study demonstrated that active noise canceling during pediatric dental care significantly reduced stress and fear, suggesting that it could be a valuable behavior guidance tool, particularly for children who find dental visits challenging.

Heat shock protein (HSP) 90 is expressed in most living organisms, and several client proteins of HSP90 are necessary for cancer cell survival and growth. Previously, we found that HSP90 was cleaved by histone deacetylase (HDAC) inhibitors and proteasome inhibitors, and the cleavage of HSP90 contributes to their cytotoxicity in K562 leukemia cells. In this study, we first established mouse xenograft models with K562 cells expressing the wild-type or cleavage-resistant mutant HSP90β and found that the suppression of tumor growth by the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) was interrupted by the mutation inhibiting the HSP90 cleavage in vivo. Next, we investigated the possible function of thioredoxin interacting protein (TXNIP) in the HSP90 cleavage induced by SAHA. TXNIP is a negative regulator for thioredoxin, an antioxidant protein. SAHA transcriptionally induced the expression of TXNIP in K562 cells. HSP90 cleavage was induced by SAHA also in the thymocytes of normal mice and suppressed by an anti-oxidant and pan-caspase inhibitor. When the thymocytes from the TXNIP knockout mice and their wild-type littermate control mice were treated with SAHA, the HSP90 cleavage was detected in the thymocytes of the littermate controls but suppressed in those of the TXNIP knockout mice suggesting the requirement of TXNIP for HSP90 cleavage. We additionally found that HSP90 cleavage was induced by actinomycin D, β-mercaptoethanol, and p38 MAPK inhibitor PD169316 suggesting its prevalence. Taken together, we suggest that HSP90 cleavage occurs also in vivo and contributes to the anti-cancer activity of various drugs in a TXNIP-dependent manner.

Paxlovid is the first approved oral treatment for coronavirus disease 2019 and includes nirmatrelvir, a protease inhibitor targeting the main protease (Mpro ) of SARS-CoV-2, as one of the key components. While some specific mutations emerged in Mpro were revealed to significantly reduce viral susceptibility to nirmatrelvir in vitro, there is no report regarding resistance to nirmatrelvir in patients and animal models for SARS-CoV-2 infection yet. We recently developed xenograft tumors derived from Calu-3 cells in immunodeficient mice and demonstrated extended replication of SARS-CoV-2 in the tumors. In this study, we investigated the effect of nirmatrelvir administration on SARS-CoV-2 replication. Treatment with nirmatrelvir after virus infection significantly reduced the replication of the parental SARS-CoV-2 and SARS-CoV-2 Omicron at 5 days post-infection (dpi). However, the virus titers were completely recovered at the time points of 15 and 30 dpi. The virus genomes in the tumors at 30 dpi were analyzed to investigate whether nirmatrelvir-resistant mutant viruses had emerged during the extended replication of SARS-CoV-2. Various mutations in several genes including ORF1ab, ORF3a, ORF7a, ORF7b, ORF8, and N occurred in the SARS-CoV-2 genome; however, no mutations were induced in the Mpro sequence by a single round of nirmatrelvir treatment, and none were observed even after two rounds of treatment. The parental SARS-CoV-2 and its sublineage isolates showed similar IC50 values of nirmatrelvir in Vero E6 cells. Therefore, it is probable that inducing viral resistance to nirmatrelvir in vivo is challenging differently from in vitro passage.

Breast cancer is the most common cancer and a frequent cause of cancer-related deaths among women wordlwide. As therapeutic strategies for breast cancer have limitations, novel chemotherapeutic reagents and treatment strategies are needed. In this study, we investigated the anti-cancer effect of synthetic homoisoflavane derivatives of cremastranone on breast cancer cells. Homoisoflavane derivatives, SH-17059 and SH-19021, reduced cell proliferation through G2/M cell cycle arrest and induced caspase-independent cell death. These compounds increased heme oxygenase-1 (HO-1) and 5-aminolevulinic acid synthase 1 (ALAS1), suggesting downregulation of heme. They also induced reactive oxygen species (ROS) generation and lipid peroxidation. Furthermore, they reduced expression of glutathione peroxidase 4 (GPX4). Therefore, we suggest that the SH-17059 and SH-19021 induced the caspase-independent cell death through the accumulation of iron from heme degradation, and the ferroptosis might be one of the potential candidates for caspase-independent cell death.